The Intestinal Microbiota and Improving the Efficacy of COVID-19 Vaccinations

Overview

Journal J Funct Foods

Publisher Elsevier

Date 2021 Nov 15

PMID 34777578

Citations 19

Authors

Jiezhong Chen

Luis Vitetta

Jeremy D Henson

Sean Hall

Affiliations

Soon will be listed here.

Abstract

Most COVID-19 cases are mild or asymptomatic and recover well, suggesting that effective immune responses ensue, which successfully eliminate SARS-CoV-2 viruses. However, a small proportion of patients develop severe COVID-19 with pathological immune responses. This indicates that a strong immune system balanced with anti-inflammatory mechanisms is critical for the recovery from SARS-CoV-2 infections. Many vaccines against SARS-CoV-2 have now been developed for eliciting effective immune responses to protect from SARS-CoV-2 infections or reduce the severity of the disease if infected. Although uncommon, serious morbidity and mortality have resulted from both COVID-19 vaccine adverse reactions and lack of efficacy, and further improvement of efficacy and prevention of adverse effects are urgently warranted. Many factors could affect efficacy of these vaccines to achieve optimal immune responses. Dysregulation of the gut microbiota (gut dysbiosis) could be an important risk factor as the gut microbiota is associated with the development and maintenance of an effective immune system response. In this narrative review, we discuss the immune responses to SARS-CoV-2, how COVID-19 vaccines elicit protective immune responses, gut dysbiosis involvement in inefficacy and adverse effects of COVID-19 vaccines and the modulation of the gut microbiota by functional foods to improve COVID-19 vaccine immunisations.

Citing Articles

Improving Vaccine Response through Probiotics and Micronutrient Supplementation: Evaluating the Role of TLR5 in Adult Female BALB/c Mice.

Eftekhari Z, Doroud D, Tajabadi-Ebrahimi M, Kazemi-Lomedasht F Curr Pharm Des. 2024; 31(3):233-242.

PMID: 39257145 DOI: 10.2174/0113816128310203240823053538.

Dietary Inulin to Improve SARS-CoV-2 Vaccine Response in Kidney Transplant Recipients: The RIVASTIM-Inulin Randomised Controlled Trial.

Singer J, Tunbridge M, Shi B, Perkins G, Chai C, Salehi T Vaccines (Basel). 2024; 12(6).

PMID: 38932337 PMC: 11209582. DOI: 10.3390/vaccines12060608.

Exploring the interaction and impact of probiotic and commensal bacteria on vitamins, minerals and short chain fatty acids metabolism.

Bermudez-Humaran L, Chassaing B, Langella P Microb Cell Fact. 2024; 23(1):172.

PMID: 38867272 PMC: 11167913. DOI: 10.1186/s12934-024-02449-3.

Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people living with HIV.

Ray S, Narayanan A, Vesterbacka J, Blennow O, Chen P, Gao Y NPJ Biofilms Microbiomes. 2023; 9(1):104.

PMID: 38123600 PMC: 10733305. DOI: 10.1038/s41522-023-00461-w.

Ginsenoside Rb1 enhanced immunity and altered the gut microflora in mice immunized by H1N1 influenza vaccine.

Wan C, Lu R, Zhu C, Wu H, Shen G, Yang Y PeerJ. 2023; 11:e16226.

PMID: 37868069 PMC: 10588687. DOI: 10.7717/peerj.16226.

References

Chiang B, Sheih Y, Wang L, Liao C, Gill H . Enhancing immunity by dietary consumption of a probiotic lactic acid bacterium (Bifidobacterium lactis HN019): optimization and definition of cellular immune responses. Eur J Clin Nutr. 2000; 54(11):849-55. DOI: 10.1038/sj.ejcn.1601093. View

Ma C, Han M, Heinrich B, Fu Q, Zhang Q, Sandhu M . Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells. Science. 2018; 360(6391). PMC: 6407885. DOI: 10.1126/science.aan5931. View

Marjot T, Webb G, Barritt A, Gines P, Lohse A, Moon A . SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question. Lancet Gastroenterol Hepatol. 2021; 6(3):156-158. PMC: 7832019. DOI: 10.1016/S2468-1253(21)00008-X. View

Weiskopf D, Weinberger B, Grubeck-Loebenstein B . The aging of the immune system. Transpl Int. 2009; 22(11):1041-50. DOI: 10.1111/j.1432-2277.2009.00927.x. View

Miyazaki A, Kandasamy S, Michael H, Langel S, Paim F, Chepngeno J . Protein deficiency reduces efficacy of oral attenuated human rotavirus vaccine in a human infant fecal microbiota transplanted gnotobiotic pig model. Vaccine. 2018; 36(42):6270-6281. PMC: 6180620. DOI: 10.1016/j.vaccine.2018.09.008. View

Xia S, Duan K, Zhang Y, Zhao D, Zhang H, Xie Z . Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials. JAMA. 2020; 324(10):951-960. PMC: 7426884. DOI: 10.1001/jama.2020.15543. View

Mathieu E, Escribano-Vazquez U, Descamps D, Cherbuy C, Langella P, Riffault S . Paradigms of Lung Microbiota Functions in Health and Disease, Particularly, in Asthma. Front Physiol. 2018; 9:1168. PMC: 6110890. DOI: 10.3389/fphys.2018.01168. View

de Jong S, Olin A, Pulendran B . The Impact of the Microbiome on Immunity to Vaccination in Humans. Cell Host Microbe. 2020; 28(2):169-179. PMC: 7422826. DOI: 10.1016/j.chom.2020.06.014. View

Hong S, Seo S, Woo S, Kwon Y, Song M, Ha N . Epigallocatechin Gallate Inhibits the Uridylate-Specific Endoribonuclease Nsp15 and Efficiently Neutralizes the SARS-CoV-2 Strain. J Agric Food Chem. 2021; 69(21):5948-5954. DOI: 10.1021/acs.jafc.1c02050. View

10.

Frenck Jr R, Klein N, Kitchin N, Gurtman A, Absalon J, Lockhart S . Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med. 2021; 385(3):239-250. PMC: 8174030. DOI: 10.1056/NEJMoa2107456. View

11.

Gautier T, David-Le Gall S, Sweidan A, Tamanai-Shacoori Z, Jolivet-Gougeon A, Loreal O . Next-Generation Probiotics and Their Metabolites in COVID-19. Microorganisms. 2021; 9(5). PMC: 8146258. DOI: 10.3390/microorganisms9050941. View

12.

Klimek L, Novak N, Hamelmann E, Werfel T, Wagenmann M, Taube C . Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA: Position statement of the German Allergy Societies: Medical Association of German Allergologists (AeDA), German Society for Allergology.... Allergo J Int. 2021; 30(2):51-55. PMC: 7903024. DOI: 10.1007/s40629-020-00160-4. View

13.

DeJong E, Surette M, Bowdish D . The Gut Microbiota and Unhealthy Aging: Disentangling Cause from Consequence. Cell Host Microbe. 2020; 28(2):180-189. DOI: 10.1016/j.chom.2020.07.013. View

14.

Akatsu H . Exploring the Effect of Probiotics, Prebiotics, and Postbiotics in Strengthening Immune Activity in the Elderly. Vaccines (Basel). 2021; 9(2). PMC: 7915329. DOI: 10.3390/vaccines9020136. View

15.

Kowalczyk A, Doener F, Zanzinger K, Noth J, Baumhof P, Fotin-Mleczek M . Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity. Vaccine. 2016; 34(33):3882-93. DOI: 10.1016/j.vaccine.2016.05.046. View

16.

Kipshidze N, Kipshidze N, Fried M . COVID-19 Vaccines: Special Considerations for the Obese Population. Obes Surg. 2021; 31(8):3854-3856. PMC: 8029603. DOI: 10.1007/s11695-021-05404-y. View

17.

Torjesen I . Covid-19: Norway investigates 23 deaths in frail elderly patients after vaccination. BMJ. 2021; 372:n149. DOI: 10.1136/bmj.n149. View

18.

Au L, Fendler A, Shepherd S, Rzeniewicz K, Cerrone M, Byrne F . Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2. Nat Med. 2021; 27(8):1362-1366. PMC: 8363501. DOI: 10.1038/s41591-021-01387-6. View

19.

Feng L, Wang Q, Shan C, Yang C, Feng Y, Wu J . An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques. Nat Commun. 2020; 11(1):4207. PMC: 7442803. DOI: 10.1038/s41467-020-18077-5. View

20.

Soiza R, Scicluna C, Thomson E . Efficacy and safety of COVID-19 vaccines in older people. Age Ageing. 2020; 50(2):279-283. PMC: 7799251. DOI: 10.1093/ageing/afaa274. View